These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7707461)

  • 1. [Current clinical approaches and gene mutation study of beta-thalassemia major].
    Chiou SS; Chang TT; Wu JR; Chang JG; Huang SF; Sheen JM; Tsai SP; Chen TS
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Feb; 11(2):98-109. PubMed ID: 7707461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis and haematological characterization of beta-thalassaemia major in Taiwan, with a mutation of IVS-1 3' end TAG-->GAG in a Chinese patient.
    Chiou SS; Chang TT; Chen PH; Lee LS; Chen TS; Chang JG
    Br J Haematol; 1993 Jan; 83(1):112-7. PubMed ID: 8435318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis of patients with beta-thalassemia major in central Taiwan by amplified created restriction site analysis.
    Peng CT; Wu JY; Tsai CH; Tsai FJ; Chang JG
    J Hum Genet; 1998; 43(4):237-41. PubMed ID: 9852674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of beta-thalassemia minor in Taiwan.
    Chang JG; Lin CP; Liu TC; Chiou SS; Chen PH; Lee LS; Chen TP
    Int J Hematol; 1994 Jun; 59(4):267-72. PubMed ID: 8086620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal and molecular diagnosis of beta-thalassemia major in Taiwan by naturally and amplified created restriction sites.
    Chiou SS; Liu TC; Chang TT; Tseng WP; Sy WD; Chang JG
    Int J Hematol; 1993 Dec; 59(1):1-8. PubMed ID: 8161731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular-genetic characteristics of alpha, beta and delta beta-thalassemias in 139 heterozygotes in 56 unrelated Czech and Slovak families (Priority description of 3 beta-thalassemia mutations, an extensive alpha-thalassemia 2 (18+ kb) deletion and a Swiss-type nondeletion hereditary persistence of hemoglobin F)].
    Indrák K; Divoký V; Brabec V; Indráková J; Svobodová M; Huisman TH
    Vnitr Lek; 1993 Oct; 39(10):969-78. PubMed ID: 7694425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
    Darwish HM; El-Khatib FF; Ayesh S
    Hemoglobin; 2005; 29(2):119-32. PubMed ID: 15921164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse phenotypes and transfusion requirements due to interaction of β-thalassemias with triplicated α-globin genes.
    Mehta PR; Upadhye DS; Sawant PM; Gorivale MS; Nadkarni AH; Shanmukhaiah C; Ghosh K; Colah RB
    Ann Hematol; 2015 Dec; 94(12):1953-8. PubMed ID: 26319530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of beta-thalassemia in South Vietnam.
    Svasti S; Hieu TM; Munkongdee T; Winichagoon P; Van Be T; Van Binh T; Fucharoen S
    Am J Hematol; 2002 Oct; 71(2):85-8. PubMed ID: 12353305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular pathology of beta-thalassemia in Turkey: the Boğaziçi university experience.
    Basak AN
    Hemoglobin; 2007; 31(2):233-41. PubMed ID: 17486506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
    Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
    Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-thalassemia intermedia in Turkey.
    Altay C; Gürgey A
    Ann N Y Acad Sci; 1990; 612():81-9. PubMed ID: 2291577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominantly Inherited beta-Thalassemia.
    Efremov GD
    Hemoglobin; 2007; 31(2):193-207. PubMed ID: 17486503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.
    Colah R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Surve R; Subramaniam PG; Bondge N; Pujari K; Ghosh K; Mohanty D
    Blood Cells Mol Dis; 2004; 33(2):153-7. PubMed ID: 15315795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States.
    Gonzalez-Redondo JM; Stoming TA; Lanclos KD; Gu YC; Kutlar A; Kutlar F; Nakatsuji T; Deng B; Han IS; McKie VC
    Blood; 1988 Sep; 72(3):1007-14. PubMed ID: 2458145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of beta-thalassemia in Syria.
    Kyriacou K; Al Quobaili F; Pavlou E; Christopoulos G; Ioannou P; Kleanthous M
    Hemoglobin; 2000 Feb; 24(1):1-13. PubMed ID: 10722110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical severity of beta-thalassemia mutations in West Malaysia.
    George E
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():225-8. PubMed ID: 8629111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of beta-thalassemia in Japan: heterogeneity and origins of mutations.
    Wakamatsu C; Ichinose M; Manabe J; Fucharoen S; Sawada H; Ohga S; Nishimura J; Nukina H; Harada T; Shirahata S
    Acta Haematol; 1994; 91(3):136-43. PubMed ID: 8091935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-thalassemia major caused by compound heterozygosity for +40 to +43(-AAAC), IVS-2-654 (C to T) and codon 41/42 (-TCTT)].
    Hu ZH; Liu YL; Zeng ZY; Zhang XL; Zhu QY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):418-20. PubMed ID: 18683140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotypes linked to three rare beta-thalassemia mutations, originally reported in Tunisia.
    Bibi A; Messaoud T; Fattoum S
    Hemoglobin; 2006; 30(2):175-81. PubMed ID: 16798642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.